Multidrug Resistance Phenotype Mediated by the P-Glycoprotein-Like Transporter in Leishmania: A Search for Reversal Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|3|4|311-333

ISSN： 1389-4501

Source： Current Drug Targets, Vol.3, Iss.4, 2002-08, pp. : 311-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dihidro-&bgr;-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-09 ,pp. : 3125-3139

Bentham Science Publishers

Access to resources Recommend Favorite

Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents

By Woodland Cindy   Koren Gideon   Wainer Irving W   Batist Gerry   Ito Shinya  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 8, 2003-08 ,pp. : 800-805

NRC Research Press

Access to resources Recommend Favorite

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

By Baranck M.   Bohacova V.   Kvackajova J.   Hudecova S.   Krizanova O.   Breier A.  

European Journal of Pharmaceutical Sciences, Vol. 14, Iss. 1, 2001-08 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

By  

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite

P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SARFuture Perspective for Drug Design

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 22, 2016-06 ,pp. : 2484-2508

Bentham Science Publishers

Access to resources Recommend Favorite